|
Variable 1
|
Variable 2
|
Correlation
|
p value
|
|---|
|
CRPS type
|
hsa-miR-532-3p
|
0.4448
|
0.00782
|
|
CRPS duration
|
hsa-miR-151-5P
|
0.45992
|
0.00574
|
|
Pain level
|
hsa-miR-296-5p
|
0.50218
|
0.00222
|
| |
hsa-miR-361-3p
|
0.48489
|
0.00333
|
| |
hsa-miR-532-3p
|
0.46868
|
0.00478
|
| |
hsa-miR-30d
|
0.43451
|
0.00957
|
|
Inmamov (inability to initiate and maintain fine movements)
|
hsa-miR-218
|
0.46241
|
0.00546
|
|
High blood pressure
|
hsa-miR-92a
|
-0.5583
|
0.0005
|
| |
hsa-miR-484
|
-0.4422
|
0.00822
|
|
High cholesterol
|
hsa-miR-219-1-3p
|
-0.4847
|
0.00334
|
| |
hsa-miR-204
|
0.46688
|
0.00497
|
|
Headache
|
hsa-miR-150
|
0.49815
|
0.00245
|
|
Thyroid disease
|
hsa-miR-616
|
0.57271
|
0.00039
|
| |
hsa-miR-548d-3p
|
0.48307
|
0.00391
|
| |
hsa-miR-27a
|
0.45319
|
0.00733
|
| |
hsa-miR-345
|
0.45319
|
0.00733
|
| |
hsa-miR-324-5p
|
0.45319
|
0.00733
|
| |
hsa-miR-192
|
0.45319
|
0.00733
|
| |
hsa-miR-28-5p
|
0.44821
|
0.00808
|
| |
hsa-miR-502-5p
|
0.44821
|
0.00808
|
|
Hyposthesia
|
hsa-let-7c
|
0.45198
|
0.00677
|
| |
hsa-miR-500
|
-0.4379
|
0.00897
|
|
Narcotics
|
hsa-miR-339-5p
|
0.54176
|
0.0008
|
| |
hsa-miR-191
|
-0.5248
|
0.00125
|
| |
hsa-miR-191#
|
0.49502
|
0.00264
|
| |
hsa-miR-486-3p
|
0.45677
|
0.00614
|
|
EpilepticDrugs
|
hsa-miR-339-3p
|
0.56671
|
0.00039
|
| |
hsa-miR-30c
|
0.49587
|
0.00258
|
| |
hsa-miR-192
|
0.4917
|
0.00285
|
| |
hsa-miR-140-3p
|
0.48337
|
0.00344
|
| |
hsa-miR-152
|
0.4667
|
0.00498
|
| |
hsa-miR-339-5p
|
0.45003
|
0.00704
|
| |
hsa-miR-145#
|
0.43337
|
0.00978
|
|
BMI
|
hsa-miR-296-5p
|
0.41312
|
0.00239
|
| |
hsa-miR-1290
|
-0.3842
|
0.00507
|
| |
hsa-miR-423-5p
|
0.38146
|
0.00544
|
| |
hsa-miR-25#
|
0.3774
|
0.00599
|
| |
hsa-miR-1270
|
0.35921
|
0.00918
|
- All additional correlations observed including inflammatory markers, groups1, 2 and 3 based on miRNA profiling, clinical parameters etc. are shown in Supplementary table 1
